Seres Therapeutics, Inc.
MCRB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $8 | -$20 | $33 | -$16 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $2 | $3 | $4 |
| Change in WC | -$12 | $1 | -$12 | -$30 |
| Other Non-Cash | $5 | $2 | $2 | $2 |
| Operating Cash Flow | $2 | -$13 | $27 | -$39 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $128 |
| Stock Issued | $0 | $0 | $1 | $2 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | -$128 |
| Financing Cash Flow | $0 | $0 | $1 | $2 |
| Forex Effect | $0 | $0 | $0 | -$0 |
| Net Chg. in Cash | $2 | -$13 | $28 | -$37 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $45 | $68 | $39 | $77 |
| End Cash | $48 | $54 | $68 | $39 |
| Free Cash Flow | $2 | -$13 | $27 | -$39 |